Skip to content

A Multicenter Randomized Controlled Trial (RCT) Study on the Efficacy of Moxibustion at the "Xinshu (HT7) and Shenshu (BL23)" Acupoints in the Treatment of Mild Cognitive Impairment in Alzheimer's Disease (AD) and Its Intervention Mechanism Mediated by Ferroptosis via the NF-?B/Caspase-1 Pathway

A Multicenter Randomized Controlled Trial (RCT) Study on the Efficacy of Moxibustion at the "Xinshu (HT7) and Shenshu (BL23)" Acupoints in the Treatment of Mild Cognitive Impairment in Alzheimer's Disease (AD) and Its Intervention Mechanism Mediated by Ferroptosis via the NF-?B/Caspase-1 Pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002501
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

Moxibustion group:Based on the control group, treatment with moxibustion using wheat grain-sized moxa cones at the HT5 (Heart) and KI3 (Kidney) acupoints was administered.
Control Group:Control blood sugar, blood pressure, cholesterol, etc., as primary prevention measures.

Sponsors

Hangzhou Municipal Traditional Chinese Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for Mild Cognitive Impairment (MCI); 2. Age = 45 years old; 3. MoCA score ranges from 19 to 25 points, with =25 points for those under 79 years old and =24 points for those aged 80 and above; 4. MMSE score ranges from 21 to 26 points, with >20 points for elementary education level, >22 points for secondary education level (including vocational high school), and >23 points for higher education level (including junior college); 5. Clinical Dementia Rating (CDR) score is 0.5; 6. Instrumental Activity of Daily Living (IADL) score is =16 points.

Exclusion criteria

Exclusion criteria: (1) Other neurological diseases that may cause cognitive impairment, such as cerebrovascular diseases, brain trauma, encephalitis, brain tumors, Parkinson's disease, multiple sclerosis, epilepsy, and normal-pressure hydrocephalus; (2) Systemic diseases that may cause cognitive impairment, such as severe anemia, impaired liver or kidney function, thyroid dysfunction, folic acid and vitamin B12 deficiency, syphilis, HIV, and drug or alcohol abuse; (3) Having undergone general anesthesia surgery within the past 3 months or experiencing cognitive impairment after general anesthesia surgery; (4) Having contraindications for MRI, such as metal implants in the body or claustrophobia; (5) Poorly controlled blood sugar levels; (6) Having other reasons that prevent compliance with examinations or follow-ups.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;Mini-Mental State Examination;

Secondary

MeasureTime frame
Instrumental Activity of Daily Living;Clinical Dementia Rating;Interleukin-2;Interleukin-4;Interleukin-6;Interleukin-10;Tumor Necrosis Factor-alpha;Interferon-?;Resting-state functional magnetic resonance imaging;

Countries

China

Contacts

Public ContactYehua Bao

Hangzhou Municipal Traditional Chinese Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine

13336101400@163.com18958076121

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026